Y.K.O. Teng
Leiden University Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Y.K.O. Teng as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:23 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04701528 · Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant RecipientsLeiden University Medical Center · completed · Covid19, Kidney Transplant Infection · principal investigator
- Ph3NCT03747159 · Synergetic B-cell Immunomodulation in SLE - 2nd Study.Leiden University Medical Center · completed · Lupus Erythematosus, Systemic · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:23 UTC. The ranking covers the 200 most relevant of 97 PubMed records, and a shared surname and initials can bring in a namesake. All 97 on PubMed
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.N Engl J Med · 2020804 citationsRCR 40.9
- 496 citationsRCR 33.9
- TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases.Cell Rep · 2012246 citationsRCR 5.8
- 232 citationsRCR 6.7
- 165 citationsRCR 14.8
- 153 citationsRCR 6.8
- Efficacy and safety of ciprofol for the sedation/anesthesia in patients undergoing colonoscopy: Phase IIa and IIb multi-center clinical trials.Eur J Pharm Sci · 2021144 citationsRCR 14.1
- Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial.Nat Med · 2024134 citationsRCR 14.2
- 127 citationsRCR 8.5
- The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus.J Autoimmun · 2018120 citationsRCR 4.5